Nevro (NYSE:NVRO) today said it appointed Julie Dewey as VP of investor relations and corporate communications, effective immediately.
Dewey has more than 25 years of experience in investor relations, corporate communications and marketing in several medical technology companies. She most recently served as senior VP and chief communications officer of Wright Medical, which was recently acquired by Stryker. She has also held numerous investor relations roles at ev3, Kyphon and Thoratec.
“Julie has a tremendous depth of experience in all areas of investor relations and corporate communications, a deep knowledge of capital markets and has earned an outstanding reputation within the investment community,” CFO Rod MacLeod said in a news release. “As a member of our leadership team, she will be instrumental in communicating the Nevro story and expanding our outreach with investors and analysts as we continue to accelerate toward long-term sustainable growth and strong financial performance for our shareholders. We are delighted to welcome Julie to the team.”
“I am thrilled to join Nevro at such a transformational time in its growth trajectory,” Dewey said. “I look forward to working with Keith Grossman, Rod MacLeod and the rest of the Nevro team to execute on the company’s growth strategy and deliver a best-in-class experience for the investment community and key stakeholders.”